Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)

South Korea · Delayed Price · Currency is KRW

3,820.00

+180.00 (4.95%)

At close: Jul 31, 2026

Jin Yang Pharmaceutical Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	122,146	120,686	113,332	93,708	76,264	62,839
Revenue Growth	4.53%	6.49%	20.94%	22.87%	21.36%	26.88%
Gross Profit	80,106	78,151	69,884	57,056	45,651	33,984
Operating Income	2,050	2,526	11,708	8,682	11,138	6,964
Net Income	22,288	22,287	29,694	12,340	12,308	9,538
Earnings Per Share	1711.54	1789.41	2408.01	988.98	915.61	835.60
EPS Growth	-32.02%	-25.69%	143.48%	8.01%	9.57%	78.63%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	6,060	5,888	2,013	8,595	10,494	14,875
Total Debt	76,371	76,757	79,682	7,831	19,982	20,013
Net Cash (Debt)	-70,311	-70,869	-77,668	764.1	-9,488	-5,138
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-5399.22	-5690.03	-6298.40	61.24	-705.79	-450.13

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	3,364	1,465	12,792	8,534	7,448	1,971
Capital Expenditures	-5,816	-4,266	-90,060	-682.28	-3,218	-2,516
Free Cash Flow	-2,452	-2,801	-77,268	7,851	4,230	-545.86
Free Cash Flow Growth	-	-	-	85.62%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	65.58%	64.76%	61.66%	60.89%	59.86%	54.08%
Operating Margin	1.68%	2.09%	10.33%	9.26%	14.61%	11.08%
Pretax Margin	23.25%	23.28%	32.69%	13.00%	19.06%	19.31%
Profit Margin	18.25%	18.47%	26.20%	13.17%	16.14%	15.18%
FCF Margin	-2.01%	-2.32%	-68.18%	8.38%	5.55%	-0.87%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	2.23	2.91	2.24	5.41	5.71	8.25
P/FCF Ratio	-	-	-	8.51	16.61	-
PS Ratio	0.40	0.54	0.59	0.71	0.92	1.25